The African Union has now secured an additional 270 million Covid-19 vaccines to be distributed among the many countries within the continent. The African Vaccine Acquisition Task Team (AVATT), however, is still not convinced that this will be enough to meet the entire nation’s demand.
From April to June at least 50 million doses of the Pfizer/BioNTech and AstraZeneca vaccines will be available according to the AVATT press release published this week. Chair President of the African Union Cyril Ramaphosa recently spoke with the media about the increase in doses that Africa is now set to receive.
“From the onset of this pandemic our focus as a continent has been on collaboration and collective effort. We have held steadfastly to the principle that no country should be left behind.”
Ramaphosa also emphasized that “all 270 million vaccine doses will be made available this year with at least 50 million being available for the crucial period of April to June 2021.” The African Union secured these doses along with a vaccine program from COVAX; a World Health Organization and Gavi Vaccine Alliance initiative that specifically works to bring more vaccines to Africa.
The WHO Regional Director for Africa, Dr. Matshidiso Moeti, recently spoke with the media to praise Africa for the acquisition of the additional doses and adoption of the program from COVAX, as it shows true initiative and will make a real difference in getting the continent vaccinated as promptly as possible.
“Covax can only cover 20% of the African population, so it’s wonderful to see the African Union’s efforts to secure a provisional 270 million doses by the end of 2021.”
President Ramaphosa did caution, however, that while this new initiative is vital for Africa’s recovery, it “may not extend beyond the needs of frontline health care workers, and may this not be enough to contain the ever-increasing toll of the pandemic in Africa.”
Africa is currently experiencing a second wave of Covid-19 that is currently higher than the peak they hit back in July 2020. The continent currently has an average daily new case count of more than 25,000 for the past 14 days.
The African Export-Import Bank will be implementing a strategy this month that will provide up to $2 billion in advancements to vaccine manufacturers in the continent. The African Union and World Bank will also be working together to grant member states access to a $5 billion fund specifically for purchasing more vaccines when needed.
The announcement of these plans couldn’t have come at a more crucial time for Africa, as Ramaphosa reported this week that South Africa is extending their Covid-19 restrictions due to a “massive increase” in Covid-19 cases driven by a new strain of the virus that is thought to be much more transmissible.
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at firstname.lastname@example.org.